Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
- Personal Care Products
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 6681
Chinese Patent Application No. 03165005.8 Title Vehicle for Topical deliver of Anti-Inflammatory Compounds.
IPSCIO Record ID: 3032
The Agreement grants the Licensee an exclusive, world-wide License for the commercialization of the liposomal delivery system for topical analgesic pain relief applications and body soak preparations and a non-exclusive, world-wide License for the commercialization of the liposomal delivery system for similar preparations such as body lotions and soap.
On April 13, 2006 the licensing and manufacturing Agreement was amended to provide for a grant to the Manufacturer of warrants to purchase 560,000 shares of the Companyâ€™s common stock.
IPSCIO Record ID: 26321
Under the terms of the Agreement executed the Licensor could receive up to $116 million in milestone payments on achievement of all regulatory and revenue targets. In addition the Licensee assumes all clinical and commercialization costs, in return for full commercialization and sub-licensing rights in the U.S and other regions.
Indaflexâ„¢ Cream is a semi-solid formulation for topical administration, containing the active ingredient Indomethacin, at a concentration of 2.5%. Indaflexâ„¢ Cream is an innovative oil-in-water emulsion formulation. There are three main features of this product which contribute to its improved efficacy as a topical analgesic drug loading/concentration, a nanoparticulate oil-in-water emulsion formulation and an improved partitioning of lipophilic drug from nanoparticles into the lipid matrix of the absorbing tissue.
Indaflexâ„¢ Cream is composed of a highly dispersed colloidal suspension of nano-sized oil droplets, loaded with active drug and suspended in an aqueous phase.
IPSCIO Record ID: 26558
Indaflex is a topical NSAID formulation intended to be used in the treatment of arthritis. Indaflex is our only prescription drug at the clinical trial stage.